You are here

  • Home
  • Archive
  • Volume 33, Issue 8
  • Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.

Article Text

Article menu
Download PDFPDF
Research Article
Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult.
  1. I Matsuda,
  2. T Matsuura,
  3. A Nishiyori,
  4. S Komaki,
  5. R Hoshide,
  6. T Matsumoto,
  7. M Funakoshi,
  8. K Kiwaki,
  9. F Endo,
  10. A Hata,
  11. M Shimadzu,
  12. M Yoshino
  1. Department of Paediatrics, School of Medicine, Kumamoto University, Japan.

    Abstract

    In five different Japanese families, we identified six male hemizygotes (aged 6, 9, 15, 17, 56, and 65 years) and a putative candidate (aged 48 years), carrying a mutant allele of the ornithine transcarbamylase (OTC) gene, a G to A substitution at nucleotide 119 in exon 2 generating histidine in place of arginine. OTC activity in the necropsied liver tissue was reduced to approximately 12% of the control and that of COS 1 cells transfected with Arg40His OTC cDNA was 10.2 +/- 1.8% of the control transfected with wild type OTC cDNA. Clinical features ranged from death during a hyperammonaemic attack (a 9 year old) to a 65 year old asymptomatic man. We consider that the amount of protein ingested by these subjects may be one predisposing factor leading to the manifestation of this disease.

    https://doi.org/10.1136/jmg.33.8.645

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.